Michael J. Munchhof , , Jean S. Beebe, Jeffery M. Casavant, Beth A. Cooper, Jonathan L. Doty, R.
Carla Higdon, Stephen M. Hillerman, Catherine I. Soderstrom, Elisabeth A. Knauth, Matthew A. Marx,
Ann Marie K. Rossi, Susan B. Sobolov and Jianmin Sun
Abstract
Graphical Abstract
Abstract
Abstract
a
Department of Organic Chemistry, Faculty of Chemical Engineering and Technology,
University of Zagreb, Marulićev trg 19, HR-10000 Zagreb, Croatia
b
Slovenian NMR Centre, National Institute of Chemistry, Hajdrihova 19, POB 660, SL-
1001 Ljubljana, Slovenia
c
Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička 54, POB 1016,
HR-10001 Zagreb, Croatia
d
Rega Institute for Medical Research, Katholieke Universiteit Leuven,
Minderbroedersstraat 10, B-3000 Leuven, Belgium
A series of the novel C-5 alkynyl pyrimidine nucleoside analogues (1–14) in which the
sugar moiety was replaced by the conformationally restricted Z- and E-2-butenyl spacer
between the phthalimido and pyrimidine ring were synthesized by using Sonogashira
cross-coupling reaction. Cytostatic activity evaluation of the novel compounds showed
that E-isomers exhibited, in general, better cytostatic activities than the corresponding Z-
isomers. E-isomer 14 exhibited the best cytostatic effect against all evaluated malignant
cell lines, particularly against hepatocellular carcinoma (Hep G2, IC50 = 4.3 μM).
However, this compound was also cytotoxic to human normal fibroblasts (WI 38). Its Z-
isomer 7 showed highly specific antiproliferative activity against Hep G2 (IC50 = 18 μM)
and no cytotoxicity to WI 38. Moreover, compounds 3, 4 and 14 expressed some
marginal inhibitory activity against HIV-1 and HIV-2.
Graphical abstract